인쇄하기
취소

Choongwae Announces KFDA Approval of Extended Indications for Provigil

Published: 2005-03-31 06:58:00
Updated: 2005-03-31 06:58:00
Choongwae Pharmaceutical announced that the Korea Food and Drug Administration (KFDA) has approved additional therapeutic indications for Provigil (active ingredient: modafinil), which is currently prescribed to over 30,000 domestic patients with excessive sleepiness associated with narcolepsy.

Developed by Cephalon Inc. of the United States, Choongwae is currently distributing Provigil in t...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.